UK clinical experience up to 52 weeks with linaclotide for irritable bowel syndrome with constipation

BACKGROUND: Linaclotide, a guanylate cyclase C agonist, has been shown in clinical trials to improve symptoms of irritable bowel syndrome with constipation (IBS-C). Here we report data from a real-world study of linaclotide in the UK. METHODS: This 1-year, multicentre, prospective, observational stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yiannakou, Yan, Agrawal, Anu, Allen, Patrick B., Arebi, Naila, Brown, Steven R., Eugenicos, Maria P., Farmer, Adam D., McLain-Smith, Su, McLaughlin, John, Sanders, David S., Lawrance, Dominic, Emmanuel, Anton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170957/
https://www.ncbi.nlm.nih.gov/pubmed/30302125
http://dx.doi.org/10.1177/1756284818798791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170957/
https://www.ncbi.nlm.nih.gov/pubmed/30302125
http://dx.doi.org/10.1177/1756284818798791

Ejemplares similares